Key Record Dates
ClinicalTrials.gov Identifier: | NCT04287686 |
---|---|
Brief Title: | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 |
First Submitted : | February 21, 2020 |
First Submitted that Met QC Criteria : | February 25, 2020 |
First Posted : | February 27, 2020 |
Last Update Submitted that Met QC Criteria : | March 15, 2020 |
Last Update Posted : | March 17, 2020 |